潜在脏捐赠者的遗传检测:目前的证据和澳大利亚的临床实践
Sadia Jahan1,2, Amali Mallawaarachchi3,4,5, Julia Jefferis2,6,7
1Central and Northern Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, SA, Australia.
Transplantation
|January 23, 2026
概括
遗传检测对于对活捐赠者的评估至关重要. 这一审查为将基因测试纳入捐赠者评估提供了一个框架,以提高捐赠者安全性和接受者获得移植的机会.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 遗传学 遗传学 是一个
- 移植 移植 移植 移植
背景情况:
- 基因检测正在从研究转向临床实践.
- 对于将基因组学纳入活体脏捐赠者的评估,存在有限的指导.
- 遗传性脏疾病是移植中日益关注的问题.
研究的目的:
- 为澳大利亚潜在的活体脏捐赠者提供基于证据的基因测试框架.
- 引导将遗传评估纳入临床实践.
- 优化供体安全和接受者获得移植的机会.
主要方法:
- 审查当前的证据和临床指导方针.
- 开发一种临床算法,用于对潜在的活体脏捐赠者的遗传评估.
- 强调多学科团队参与和遗传咨询.
主要成果:
- 捐赠者的遗传评估需要先在接受者身上进行诊断.
- 相关捐赠者的级联测试是必不可少的,但需要细微的解释.
- 基因检测应该补充,而不是取代传统的供体评估.
结论:
- 提出了一个框架和临床算法,用于活体脏捐赠者的遗传测试.
- 对于不确定的风险病例,建议在专门诊所进行共享决策.
- 关键原则包括遗传咨询,多学科团队,级联测试和公平获取.
相关概念视频
The Evidence for Evolution
47.7K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
47.7K
Chronic Kidney Disease II: Clinical Manifestations
598
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
598
Acute Kidney Injury III: Clinical Manifestations
857
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
857
Myocarditis II: Clinical Features and Diagnostic Tests
294
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
294
Pericarditis II: Clinical Features and Diagnostic Tests
309
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
309
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
495
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
495


